T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Targa Resources
TRGP
$57.2B
| $12.7M | ﹤0.01% |
120,100
+12,800
| +12% | +$1.48M |
|
|
ACOR
1252
DELISTED
Acorda Therapeutics
ACOR
| $12.7M | ﹤0.01% |
2,588
+16
| +0.6% | +$68.7K |
|
|
AENZ
1253
DELISTED
Aenza S.A.A.
AENZ
| $12.7M | ﹤0.01% |
334,067
+36,400
| +12% | +$1.42M |
|
|
ILG
1254
DELISTED
ILG, Inc Common Stock
ILG
| $12.7M | ﹤0.01% |
605,817
+585,613
| +2,899% | +$12.4M |
|
|
TTM
1255
DELISTED
Tata Motors Limited
TTM
| $12.4M | ﹤0.01% |
293,444
-8,033
| -3% | -$358K |
|
1256
Deckers Outdoor
DECK
$12.7B
| $12.4M | ﹤0.01% |
815,130
+19,770
| +2% | +$301K |
|
1257
Essent Group
ESNT
$6.23B
| $12.3M | ﹤0.01% |
479,390
-44,300
| -8% | -$1.05M |
|
1258
Cincinnati Financial
CINF
$26.5B
| $12.2M | ﹤0.01% |
236,219
-1,290
| -0.5% | -$64.5K |
|
|
SNI
1259
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $12.2M | ﹤0.01% |
162,580
-13,890
| -8% | -$1.06M |
|
|
ESV
1260
DELISTED
Ensco Rowan plc
ESV
| $12.2M | ﹤0.01% |
101,881
+1,233
| +1% | +$177K |
|
1261
Globe Life
GL
$14B
| $12.2M | ﹤0.01% |
225,226
-1,400
| -0.6% | -$74.2K |
|
|
PTLA
1262
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $12.2M | ﹤0.01% |
429,975
-87,678
| -17% | -$2.44M |
|
|
SSI
1263
DELISTED
Stage Stores Inc
SSI
| $12.1M | ﹤0.01% |
586,840
-967,060
| -62% | -$17.4M |
|
1264
Clarus
CLAR
$145M
| $12.1M | ﹤0.01% |
1,393,928
+3,113
| +0.2% | +$25.7K |
|
1265
Agios Pharmaceuticals
AGIO
$2B
| $12.1M | ﹤0.01% |
+107,580
| New | +$9.6M |
|
|
TVTY
1266
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $12M | ﹤0.01% |
601,830
+5,700
| +1% | +$93.1K |
|
|
GAS
1267
DELISTED
AGL Resources Inc
GAS
| $11.9M | ﹤0.01% |
219,016
+4,900
| +2% | +$259K |
|
1268
WSFS Financial
WSFS
$4.17B
| $11.8M | ﹤0.01% |
460,590
+450,840
| +4,624% | +$11.4M |
|
1269
Supernus Pharmaceuticals
SUPN
$2.74B
| $11.8M | ﹤0.01% |
1,421,832
-935,818
| -40% | -$7.86M |
|
|
POM
1270
DELISTED
PEPCO HOLDINGS, INC.
POM
| $11.7M | ﹤0.01% |
435,400
+7,500
| +2% | +$203K |
|
1271
Hormel Foods
HRL
$13.4B
| $11.7M | ﹤0.01% |
448,696
+2,000
| +0.4% | +$52.7K |
|
1272
Rollins
ROL
$17.4B
| $11.7M | ﹤0.01% |
1,191,770
+115,088
| +11% | +$1.08M |
|
|
SNMX
1273
DELISTED
Senomyx, Inc.
SNMX
| $11.6M | ﹤0.01% |
1,935,865
+29,000
| +2% | +$186K |
|
1274
Protolabs
PRLB
$2.21B
| $11.6M | ﹤0.01% |
+172,915
| New | +$11.4M |
|
|
OXFD
1275
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $11.6M | ﹤0.01% |
849,900
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.